CellZome

About:

CellZome is a pharmaceutical company that discovers, develops, and commercializes kinase-targeted drugs.

Top Investors: Sofinnova Investments, Index Ventures, Advent International, Schroders, Atlas Venture

Description:

CellZome is a pharmaceutical company that discovers, develops, and commercializes kinase-targeted drugs for the treatment of inflammatory diseases. It develops a pipeline of kinase inhibitors targeting inflammatory mediators as oral therapeutics for rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, psoriasis, and asthma. CellZome was founded in 2000 and is based in Heidelberg, Baden-Wurttemberg.

Total Funding Amount:

$69.3M

Headquarters Location:

Heidelberg, Baden-Wurttemberg, Germany

Founded Date:

2000-01-01

Founders:

Bernard Gilly, Stelios Papadopoulos

Number of Employees:

51-100

Last Funding Date:

2008-11-25

IPO Status:

Private

Industries: